MyAverix Finance
TWO · Healthcare
Feng Chi Biotech Corp. (6744)
Biotechnology
Feng Chi Biotech Corp. (6744) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $242.55M, P/E ratio is 15.59, net margin is 8.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6744
Feng Chi Biotech Corp. (6744) — FAQ
What is Feng Chi Biotech Corp.'s market cap?
Feng Chi Biotech Corp. (6744) has a reported market cap of $242.55M (data as of 2026-03-29).
What is 6744's P/E ratio?
The price-to-earnings (P/E) ratio for Feng Chi Biotech Corp. (6744) is 15.59 (data as of 2026-03-29).
Does Feng Chi Biotech Corp. pay a dividend?
Dividend yield is not available in the current snapshot for Feng Chi Biotech Corp. (6744). Check the MyAverix Finance app for the latest dividend data.
What sector is Feng Chi Biotech Corp. in?
Feng Chi Biotech Corp. (6744) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 6744 listed on?
6744 is listed on TWO.
What is Feng Chi Biotech Corp.'s net margin?
Feng Chi Biotech Corp. (6744) reports a net margin of 8.7% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.